AlzeCure Pharma AB Sustainability Reports

AlzeCure Pharma AB is a Swedish pharmaceutical company focused on the research and development of small-molecule therapeutics for diseases affecting the central nervous system, particularly Alzheimer's disease and chronic pain. The company evaluates drug candidates through its three platforms: NeuroRestore, Alzstatin, and Painless.

Sector: Manufacturing

Country: Sweden

Exchange: Nasdaq Stockholm

LEI: 5493001EJLEBXFY6I446

FIGI: BBG00M6GTHR1

12 reports from 2019 to 2025

• AlzeCure Pharma AB 2025 Annual Report
• AlzeCure Pharma AB 2025 Corporate Governance Report
• AlzeCure Pharma AB 2024 Annual Report
• AlzeCure Pharma AB 2023 Corporate Governance Report
• AlzeCure Pharma AB 2023 Annual Report